Chapters

Transcript

Video

In phase 1 of the CAHtalyst pediatric study, did investigators demonstrate a statistically significant decrease in serum androstenedione from baseline with crinecerfont at Week 4 over baseline?

In phase 1 of the CAHtalyst pediatric study, did investigators demonstrate a statistically significant decrease in serum androstenedione from baseline with crinecerfont at Week 4 over baseline?


Created by

CMEducation Resources | iQ&A Congenital Adrenal Hyperplasia (CAH) Medical Intelligence Zone 

Presenter

Phyllis W. Speiser, MD

Phyllis W. Speiser, MD

Associate Professor, Institute of Molecular Medicine
Feinstein Institutes for Medical Research
Emerita Professor, Pediatrics Donald and Barbara Zucker School of Medicine
Hofstra/Northwell
New Hyde Park, NY